GEN Live: Vanquishing the Virus

In this on demand debut of “GEN Live”, Julianna LeMieux and Alex Philippidis discuss the latest medical advances in drug and vaccine development, as well as diagnostic and antibody testing. They go beyond the written word to share news and insights, ranking the frontrunner drug and vaccine candidates aiming to vanquish the virus. Attendees were able to ask questions live or via chat/social media.
IEDA Iowa webinar image

Iowa’s One Health Initiatives for Vaccine Development

In this GEN webinar, we will hear a series of presentations highlighting some of the high-quality bioscience research that is emerging from various industries across Iowa. Specifically, two of our presenters will discuss not only the manufacturing and testing capabilities to advance new vaccine candidates into clinical trials, but also some of the technological advances, facilities, and infrastructure that are being applied to pandemic preparedness and rapid vaccine development.
R&D Biotechne lead image

Kicking Up an Immune System Storm: COVID-19 and Hyper-Inflammation

In TODAY's webinar, sponsored by R&D Systems, we will learn about the cellular and systemic conditions that regulate the hyper-inflammatory condition known as cytokine storm syndrome (CSS). This disorder has seen renewed interest, as it has been associated with a number of SARS-CoV-2 infections, an area that will also be discussed.
cancer cell

Organoids and Spheroids Help Science See in 3D

In this GEN webinar, sponsored by Corning, we will hear from two investigators who are employing organoids and spheroids in their respective research endeavors.
crispr

A CRISPR Vision for the Future of Cell Therapy

In this webinar from GEN and The CRISPR Journal, T.J. Cradick, PhD, —who was until recently head of genome editing at CRISPR Therapeutics—will introduce how genome editing is used to engineer cell therapies.
Embryonic stem cells

Looking toward the Future of Cell & Gene Therapies

In this GEN webinar, sponsored by PerkinElmer, our expert speakers, who are leading investigators in the field of cell and gene therapy, will discuss emerging gene-edited and engineered cell therapies for cancer, as well as the next generation of AAV vectors for human gene therapy.
Antibody, illustration

DNA as Medicine: Encoding Cancer Therapeutic Antibodies

In this GEN webinar, sponsored by Sartorius, we will hear from two members of the clinical development and discovery research teams at Inovio. We will learn about the novel DNA-encoded monoclonal antibody (dMab™) technology and how it is being employed for cancer therapies. Additionally, our presenters will describe some current pre-clinical work using DNA-encoded immune cell engagers (DICE).
lab equipment

Streamlining High-Throughput Impurity Analysis in Process Development

In this GEN webinar, we will hear about some of the latest advances in high-throughput analytics, with particular attention on the High-Throughput Impurity Detection platform for automated impurity quantitation from Lonza.
DNA and genome editing

CRISPR-Based In Vivo Genome Editing and Base Editing

In this GEN webinar, Dr. Wen Xue will present a modular delivery strategy for homology-directed repair by combining lipid nanoparticle delivery of Cas9 mRNA with adeno-associated viruses (AAV) encoding a sgRNA and a repair template.
COVID-19 anibodies

Rapid Discovery of Functional Antibodies for SARS-CoV-2 Using the Beacon System

In this GEN webinar, sponsored by Berkeley Lights, we will hear from Anupam Singhal, PhD, who will provide a brief overview of how antibody discovery on the Beacon optofluidic system can be used to screen human B cells for the discovery of antiviral antibodies in under one week. Robert Carnahan, PhD, and Seth Zost, PhD, from the Vanderbilt University Medical Center, will then describe how they have used the Beacon system, to rapidly discover hundreds of unique antibodies against SARS-CoV-2.

Recently Featured

Scroll Up